Press Releases April 8, 2026 08:00 PM

Lithia & Driveway (LAD) Schedules Release of First Quarter 2026 Results

Lithia & Driveway Announces Q1 2026 Earnings Release Date and Conference Call

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
LAD

Lithia & Driveway, the largest global automotive retailer, announced that it will release its first quarter 2026 earnings and full year results before the market opens on April 29, 2026. A conference call to discuss these results is scheduled for the same day. The company continues to focus on modernizing personal transportation with a diversified and comprehensive automotive retail model.

Lithia & Driveway (LAD) Schedules Release of First Quarter 2026 Results
LAD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Lithia & Driveway will release its Q1 2026 earnings and full year results on April 29, 2026.
  • A conference call is scheduled to discuss the earnings results, accessible both via telephone and online.
  • The company is celebrating 80 years in business and operates in automotive retail, e-commerce platforms, captive finance, and fleet management, emphasizing convenience and transparency.

MEDFORD, Ore., April 09, 2026 (GLOBE NEWSWIRE) -- Lithia & Driveway (NYSE: LAD) today announced its first quarter 2026 earnings and full year results will be released before the market opens on Wednesday, April 29, 2026. A conference call to discuss the earnings results is scheduled for the same day at 10:00 a.m. Eastern Time.

How to Participate

The conference call may be accessed by telephone at (877) 407-8029. To listen live on our website, or for replay, visit investors.lithiadriveway.com and click on quarterly earnings.

About Lithia & Driveway (LAD)
Lithia & Driveway (NYSE: LAD) is the largest global automotive retailer making Auto Done Easy by providing simple, transparent, and convenient experiences throughout the ownership lifecycle. LAD helps customers take care of any vehicle need through a comprehensive network of physical locations, e-commerce platforms, captive finance solutions, fleet management offerings, and other synergistic adjacencies. Celebrating 80 years in business in 2026, LAD consistently delivers profitable growth in a massive and unconsolidated industry. Its highly diversified and competitively differentiated design provides LAD with the flexibility and scale to pursue its vision to modernize personal transportation solutions wherever, whenever and however consumers desire.

The 80th Celebration
https://www.lithiadriveway.com/80-years

Connect with Us!
All Cars: https://www.lithia.com
Driveway.com (Buy, sell, trade, or finance entirely online): https://www.driveway.com
GreenCars (All things sustainable vehicles): https://www.greencars.com
DFC (Auto Financing): https://www.drivewayfinancecorp.com
Investor Relations: https://investors.lithiadriveway.com/
Careers: https://www.lithiacareers.com
Lithia & Driveway on Instagram
https://www.instagram.com/lithiamotors/?hl=en
https://www.instagram.com/driveway_hq/
Lithia & Driveway on Facebook
https://www.facebook.com/lithiaanddriveway/
https://www.facebook.com/DrivewayHQ
Lithia & Driveway on X
https://x.com/lithiadriveway
https://x.com/DrivewayHQ
https://x.com/GreenCarsHQ
Lithia & Driveway on LinkedIn
https://www.linkedin.com/company/lithia-motors/
Lithia & Driveway on YouTube
https://www.youtube.com/@LithiaDriveway

Media Contact

[email protected] 


Risks

  • Earnings results may not meet market expectations, causing potential stock volatility.
  • The automotive retail sector faces macroeconomic uncertainties such as fluctuating consumer demand and supply chain disruptions.
  • Competition in automotive e-commerce and financing could impact company growth and profitability.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026